Serum Institute seeks DCGI’s nod to manufacture Sputnik V vaccine

Russia's Sputnik V vaccine is currently being manufactured by Dr Reddy's Laboratories in India.

Medicine Injection Vaccine
Picture: Pixabay

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V C-19 vaccine for examination, test and analysis at its licensed Hadapsar facility in Pune, official sources said on Thursday.

The Pune-based firm has collaborated with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow for developing Sputnik V at its Hadapsar facility.

On May 18, the SII had also applied to the Review Committee on Genetic Manipulation (RCGM), Department of Biotechnology seeking clearance for the import of strains or seed lots and cell banks and for carrying out research and development, the sources said.

Injection vaccine Medicine
Picture: Pixabay

The RCGM has raised certain queries over the SII’s application and sought a copy of the material transfer agreement between the Pune-based firm and the Gamaleya Research Institute of Epidemiology and Microbiology.

Russia’s Sputnik V vaccine is currently being manufactured by Dr Reddy’s Laboratories in India.

“The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture C-19 vaccine Sputnik V for examination, test and analysis at its licensed Hadapsar facility,” an official source said.

Once these approvals are received, the SII plans to seek restricted emergency use permission for the vaccine in India.

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

The vaccine was given emergency use authorisation (EUA) by the DCGI in April. A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.

Green signal: Moderna vaccines may soon be available in India

Drug alert: 23 out of 931 samples declared as NSQ in…

Govt issues operational guidelines for Pharma PLI scheme

USFDA accepts application from Lupin for Pegfilgrastim Biosimilar

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

Glenmark launches drug for the treatment of seizures

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner